Viewing nowCabalin CR Sustained Release Tablet 150 mg (Pregabalin)
Pregabalin 70mg
Tablet · Prescription medication
GL Pharmtech Co., Ltd.

MFDS item code 201900145 · Approved 2019.01.11 · Insurance code 624200030
Treatment of peripheral neuropathic pain in adults
This medication is used to treat pain caused by peripheral neuropathy in adults.
1. This medicine should be administered once daily after the evening meal. It should be swallowed whole and should not be split, crushed, or chewed. Adults: A starting dose of 150 mg per day may be administered. Based on each patient's response and tolerability, the dose may be increased at weekly intervals to a maximum of 600 mg per day. Discontinuation: Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually, with intervals of at least 1 week. 2. Patients with renal impairment The safety and efficacy of this medicine have not been established in patients with renal impairment. 3. Patients with hepatic impairment The safety and efficacy of this medicine have not been established in patients with hepatic impairment. 5. Older adults (aged 65 years or older) The safety and efficacy of this medicine have not been established in older adults aged 65 years or older.
4. Pediatric and adolescent patients The safety and efficacy of this medicine have not been established in pediatric and adolescent patients under 19 years of age.
This medication may increase the risk of suicidal thoughts or behaviors; therefore, if any symptoms of depression or changes in mood occur during treatment, you must inform your healthcare provider immediately. Patients allergic to pregabalin or any components of this medication should not take it. Diabetic patients may experience weight gain after taking this medication, which may require adjustments in their blood sugar control medications. If allergic reactions, such as angioedema, occur, discontinue use immediately and consult a doctor. Elderly patients may experience increased dizziness or drowsiness, so caution should be exercised during the initial treatment period to avoid falls or accidents. Transient blurred vision or changes in vision may occur; if these symptoms appear, you should consult a doctor. Abrupt discontinuation of this medication may lead to withdrawal symptoms, such as insomnia, headaches, nausea, and anxiety; therefore, it should be gradually reduced according to the physician's instructions. Due to the risk of drug abuse, patients with a history of substance abuse or mental disorders should be particularly cautious. Patients with impaired kidney function should have their dosage adjusted, and patients with severe heart conditions should also take this medication with caution. Taking this medication with opioid analgesics may increase the risk of central nervous system depression; caution is advised. Patients with compromised respiratory function or the elderly may have an increased risk of severe respiratory depression and may require dosage adjustments during treatment. It is recommended not to take this medication in early pregnancy due to the risk of fetal malformations, and women of childbearing age should use effective contraception. Breastfeeding women should consult their doctors regarding whether to discontinue breastfeeding or the medication, as this medication may pass into breast milk and affect the infant. It is advisable to avoid hazardous activities such as driving or operating machinery until dizziness or drowsiness has resolved after taking this medication. In the event of an overdose, symptoms such as confusion, drowsiness, depression, and seizures may arise, and immediate medical treatment should be sought.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly closed container to avoid exposure to air or moisture. It is important to maintain storage temperatures between 1°C and 30°C to safely preserve the medication's effectiveness.
White to light yellow, rectangular film-coated sustained-release tablet.
30 tablets (6 tablets/PTP x 5)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 70mg
Tablet · Prescription medication
GL Pharmtech Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.